A Randomized Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's Disease

PHASE2TerminatedINTERVENTIONAL
Enrollment

510

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

September 30, 2006

Conditions
Alzheimer's Disease
Interventions
DRUG

FK962

Trial Locations (84)

10021

Investigational Site, New York

10605

Investigational Site, White Plains

11559

Investigational Site, Lawrence

12208

Investigational Site, Albany

14221

Investigational Site, Buffalo

19004

Investigational Site, Bala-Cynwyd

19046

Investigational Site, Jenkintown

21208

Baltimore

23507

Investigational Site, Norfolk

28204

Charlotte

30078

Investigational Site, Snellville

Snellville

32401

Hattiesburg

33016

Investigational Site, Hialeah

33021

Investigational Site, Hollywood

33161

Investigational Site, North Miami

33176

Investigational Site, Miami

33407

West Palm Beach

33613

Investigational Site, Tampa

33872

Investigational Site, Sebring

33912

Investigational Site, Fort Myers

33952

Investigational Site, Port Charlotte

34243

Investigational Site, Sarasota

34471

Investigational Site, Ocala

37203

Investigational Site, Nashville

37601

Investigational Site, Johnson City

43210

Investigational Site, Columbus

43623

Investigational Site, Toledo

45408

Dayton

45415

Investigational Site, Dayton

45459

Investigational Site, Centerville

48152

Livonia

53227

Investigational Site, Milwaukee

60007

Investigational Site, Elk Grove

63128

Investigational Site, St Louis

67207

Investigational Site, Wichita

70112

Investigational Site, New Orleans

72205

Investigational Site, Little Rock

72211

Investigational Site, Little Rock

73112

Investigational Site, Oklahoma City

74104

Investigational Site, Tulsa

76309

Investigational Site, Wichita Falls

77063

Investigational Site, Houston

78229

Investigational Site, San Antonio

80249

Investigative Site, Denver

80262

Investigational Site, Denver

84121

Investigational Site, Salt Lake City

85013

Investigational Site, Phoenix

85032

Investigational Site, Phoenix

85351

Sun City

85724

Investigational Site, Tucson

87102

Investigational Site, Albuquerque

89102

Investigational Site, Las Vegas

90505

Investigational Site, Torrance

91403

Investigational Site, Sherman Oaks

92618

Investigational Site, Irvine

92656

Investigational Site, Orange

93720

Investigational Site, Fresno

94115

Investigational Site, San Francisco

97401

Investigational Site, Eugene

97504

Investigational Site, Medford

06820

Investigational Site, Darien

06518

Investigational Site, Hamden

Hamden

06902

Investigational Site, Stamford

02459

Investigational Site, Newton

07740

Investigational Site, Long Branch

08759

Investigational Site, Paterson

08855

Investigational Site, Piscataway

02860

Investigational Site, Pawtucket

05201

Investigational Site, Bennington

05401

Burlington

V1Y3G8

Investigational Site, Kelowna

V2A5C8

Investigational Site, Penticton

V8T5G1

Investigational Site, Victoria

B1P1C6

Investigational Site, Sydney

L4M4S5

Investigational Site, Barrie

P3E6B4

Investigational Site, Greater Sudbury

M2J5A3

Investigational Site, North York

M6M3C5

Investigational Site, North York

K1G 4C3

Investigational Site, Ottawa

M6M3Z5

Investigational Site, Toronto

M2K2Z3

Investigational Site, Willowdale

S4T1A5

Investigational Site, Regina

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma US, Inc.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY